Essenzaa Nutrition: Driving Innovation & Global Growth With Personalized Products

Siddharth Shah, Dr. Kunal Shah, Founder

Siddharth Shah, Dr. Kunal Shah

Founder

Globally, the nutraceutical market stands at approximate­ly $700 billion as of 2024, growing at a steady rate of 8-9 percent annually. While the global market is more developed and grows at a steadier pace, the Indian market is experiencing exponential growth, increasing from $4 billion in 2017 to an anticipated $18 billion by next year. This surge is largely driven by a growing consumer focus on health-promot­ing diets and preventive healthcare. In terms of developments, innovation has been a key driver in the supplement industry, with new dosage forms emerging, and a strong trend toward personalized product development. Brands are increasingly focusing on tailored supplements that meet individual needs. Sustainability has also become a major focus, with eco-friend­ly practices and packaging becoming industry standards, as brands aim to reduce their environmental impact. With the ability to understand and adapt to industry trends, such as con­sumer awareness and the rise of personalized healthcare, Es­senzaa Nutrition has positioned itself well to capitalize on the ongoing growth of the nutraceutical industry.

R&D Driven Excellence

Essenzaa Nutrition is a herbal and nutraceutical contract manufacturer with a strong R&D and regulatory affairs capability, focussing on research and quality. “We have patents approved in the U.S., India, and China, and are one of the earliest in India to secure the U.S. FDA approval under 21 CFR Part 111”, says Dr. Kunal Shah, Founder at Essenzaa Nutrition. The company’s rigorous quality control measures, including third-party testing from NABL-approved laboratories and in-house testing of raw materials and finished products, guarantee that customers receive only the highest quality products. “We are a one stop shop for all the supplement needs with presence in 30 countries, endorsed by 5000+ doctors, 350 ready formulations and one million hours in R&D and counting”, he adds.

Research and development remain a key strength of Essenzaa Nutrition. The company was initially founded as an R&D-focused organization, and this expertise remains at the core of its operations. With a strong team of doctors, nutritionists, and scholars, it continues to push the boundaries of product development in the nutraceutical and Ayurvedic sectors. The collaborative R&D efforts with government bodies and institutes have led to the successful patenting of products across three major markets, further validating its innovative approach.

Regulatory Affairs Department

To meet the demands of the evolving market, Essenzaa Nutrition has implemented several practical measures within its contract manufacturing operations. It boasts of an ultra modern manufacturing facility with fully automatic cGMP machineries, clean room environment with AHU with HEPA Filters, epoxy floors, in-house laboratory and a strong QA/QC Department. A dedicated in-house Regulatory Affairs Department ensures full compliance with the regulatory guidelines of each country it exports to. The department also aids clients in documentation, labeling, and product registration processes, making the company a one-stop shop for all their manufacturing needs. Its capabilities span product research, formulation, testing, packaging development, regulatory compliance, and more. This comprehensive approach means clients can focus solely on marketing while the company handles everything from ideation to final product dispatch.

Lifecycle Product Support Solutions

By offering a full range of services, from ideation to product distribution, it ensures that clients’ needs are met at every stage of the product life cycle. The company goes a step further by distributing products directly to clients’ warehouses, whether located in-house or through third-party logistics (3PL) providers. In addition, Essenzaa Nutrition splits goods and distributes them to separate locations, enabling clients to focus solely on marketing their products, while it takes care of all technical aspects.

We are a one stop shop for all the supplement needs with presence in 30 countries, endorsed by 5000+ doctors, 350 ready formulations and one million hours in R&D and counting

Siddharth Shah, Dr. Kunal Shah, Founder

A key strength of the company lies in its dedicated Client Servicing team, which remains in constant communication with clients to understand their challenges and pain points. This proactive approach allows the team to evolve and adapt, ensuring the delivery of high-quality products and solving practical issues. For instance, when a client faced difficulties with distributors unwilling to spend time shipping smaller quantities to retail, the company devised a solution by creating smaller 12-piece shippers within larger packages. This change resulted in a significant boost in sales for the client.

Efficient Issue Escalation System

One strategy that it follows to ensure customer satisfaction is holding regular meetings with all customers, at least once a week. To facilitate easy communication, the company has established WhatsApp groups for each customer, connecting the entire customer segment hierarchy. These groups are strictly strategic, focusing only on success, challenges, and future growth. The presence of both the client’s and the company’s directors in these groups allows for lateral escalation, enabling direct intervention when the team is unable to resolve a problem. This setup speeds up the response time, reducing the turnaround time (TAT) for addressing customer issues. Key departments are also part of these groups, allowing them to take swift action when necessary.

In addition, Essenzaa Nutrition has a dedicated Corrective and Preventive Action (CAPA) department, consisting of a team of four people. While they assist with operations when there are no complaints, their primary responsibility is to handle customer feedback and complaints. When activated, the CAPA team works to resolve issues promptly and implements policies to prevent similar problems in the future. They track complaints and ensure corrective actions are taken, reducing the likelihood of recurring errors. This structured approach to feedback management plays a critical role in maintaining high levels of customer satisfaction.

As Essenzaa Nutrition looks to the future, its strong focus on R&D, regulatory compliance, and client-centric solutions positions it as a leading force in the nutraceutical contract manufacturing segment. Its goal is clear: to continue expanding its global reach while maintaining the highest standards of quality and innovation.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.